top of page

W E L C O M E !

Our Research

At the McFall lab, we are passionate about conducting groundbreaking research in the cancer field. Our team is dedicated to exploring new mechanisms and data analysis techniques to drive the development of effective cancer treatments. We take pride in our unique approach and are commited to making a difference in the fight against cancer.

Who Are We?

Through the development of isogenic cell line models utilizing CRISPR-Cas9 genome editing, we investigate Ras function in clinically relevant contexts, with particular emphasis on pancreatic ductal adenocarcinoma, non-small cell lung cancer, and colorectal cancer. Our integrated approach combines advanced biochemical and biophysical methodologies to dissect the unique molecular mechanisms underlying individual Ras mutants. This work aims to provide the foundational knowledge necessary for the development of precision oncology strategies, ultimately improving therapeutic outcomes for patients harboring specific Ras alterations.

Our Publications

Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach

EGFR inhibitors have been found to be really effective for certain CRC patients

NF1 binding affinity is critical for the proliferation of these CRC cells

Emergence of differences in structural biology of these mutations may open new conclusions

Oil and Water
NIH LOGO use this one.png

We would like thank our main sources of funding as we would not be here without them.

To contact us leave your email below and we will be sure to reach out as soon as possible!

MCW Biochemistry.png

9200 W Wisconsin Ave, Milwaukee, WI 53226

mcfall-lab.com

414-944-2823

© 2025 by The McFall Lab. Powered and secured by Wix

bottom of page